Yayın:
Vanadate treatment reverses gastrointestinal complications in the streptozotocin-diabetic rats

dc.contributor.authorÖZTÜRK, YUSUF
dc.contributor.authorNuray Arı
dc.contributor.authorCan Pekiner
dc.contributor.authorA. Tanju Özçelikay
dc.contributor.authorV.Meli̇h Altan
dc.contributor.orcid0000-0002-9488-0891
dc.contributor.orcid0000-0002-9259-7427
dc.contributor.orcid0000-0001-9142-9061
dc.contributor.orcid0000-0001-7125-3900
dc.date.accessioned2025-11-13T12:13:54Z
dc.date.issued1994-10-01
dc.identifier.doihttps://doi.org/10.1016/0306-3623(94)90125-2
dc.identifier.endpage1114
dc.identifier.issn0306-3623
dc.identifier.issue6
dc.identifier.openalexW2044681396
dc.identifier.startpage1109
dc.identifier.urihttps://hdl.handle.net/11421/9373
dc.identifier.urihttps://doi.org/10.1016/0306-3623(94)90125-2
dc.identifier.volume25
dc.language.isoen
dc.relation.ispartofGeneral Pharmacology The Vascular System
dc.rightsrestrictedAccess
dc.subjectVanadate
dc.subjectInternal medicine
dc.subjectStreptozotocin
dc.subjectEndocrinology
dc.subjectInsulin
dc.subjectDuodenum
dc.subjectDiabetes mellitus
dc.subjectMedicine
dc.subjectGastrointestinal tract
dc.subjectSodium orthovanadate
dc.subjectAdrenergic
dc.subjectChemistry
dc.subjectBiochemistry
dc.subject.sdg6
dc.titleVanadate treatment reverses gastrointestinal complications in the streptozotocin-diabetic rats
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5012641576

Dosyalar

Koleksiyonlar